C-peptide, a biomarker that indicates insulin production, is a validated surrogate endpoint in type 1 diabetes clinical trials NEW YORK, May 20, 2024 /PRNewswire/ — A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.